Do Angioplasty Patients Really Need Beta-Blocker Drugs?

TUESDAY, Aug. 16, 2016 -- Doctors might be overprescribing beta-blocker medications to heart patients who aren't seriously ill, a new study contends. Beta blockers such as Inderal (propranolol) and Lopressor (metoprolol) reduce blood pressure and...
Source: - Daily MedNews - Category: Journals (General) Source Type: news

Related Links:

ConclusionsA clinically relevant model of PTA of venous stenosis in mice was created. PTA-treated vessels had increased lumen vessel area and WSS. The alterations in tissue markers of vascular remodeling, tissue hypoxia, proliferation, and cell death may be implications for future design of drug and device development.
Source: Journal of Vascular and Interventional Radiology - Category: Radiology Source Type: research
Authors: Li Y, Yuan M, Yu M, Lu Z, Shen C, Wang Y, Lu B, Zhang J Abstract OBJECTIVE: To study the prevalence and clinical characteristics of decreased myocardial blood flow (MBF) quantified by dynamic computed tomography (CT) myocardial perfusion imaging (MPI) in symptomatic patients without in-stent restenosis. MATERIALS AND METHODS: Thirty-seven (mean age, 71.3 ± 10 years; age range, 48-88 years; 31 males, 6 females) consecutive symptomatic patients with patent coronary stents and without obstructive de novo lesions were prospectively enrolled to undergo dynamic CT-MPI using a third-generation dual-sou...
Source: Korean Journal of Radiology - Category: Radiology Tags: Korean J Radiol Source Type: research
CONCLUSIONS: The experimental treatment strategy of one-month DAPT followed by 23 months of ticagrelor alone did not result in a significant reduction in the rates of site-reported POCE or NACE, when compared to the reference treatment. PMID: 30888959 [PubMed - as supplied by publisher]
Source: EuroIntervention - Category: Cardiovascular & Thoracic Surgery Tags: EuroIntervention Source Type: research
Publication date: April 2019Source: Revista Española de Cardiología (English Edition), Volume 72, Issue 4Author(s): Juan Sanchis, Sergio García-Blas, Luis Ortega-Paz, Ana Paula Dantas, Enrique Rodríguez, Lidia Abellán, Salvatore Brugaletta, Ernesto Valero, Gema Miñana, Manuel Garabito, África Corchón, Julio Núñez, Arturo Carratalá, Manel SabatéAbstractIntroduction and objectivesCell-free DNA (cfDNA) in ST-segment elevation myocardial infarction might originate from hyperactivated leukocytes at the coronary lesion. Our aim was to investigate...
Source: Revista Espanola de Cardiologia - Category: Cardiology Source Type: research
bos-Gil MÁ PMID: 30883220 [PubMed - in process]
Source: Circulation - Category: Cardiology Authors: Tags: Circulation Source Type: research
To develop a clinically relevant model of percutaneous transluminal angioplasty (PTA) of venous stenosis in mice with arteriovenous fistula (AVF); to test the hypothesis that there is increased wall shear stress (WSS) after PTA; and to histologically characterize the vessels.
Source: Journal of Vascular and Interventional Radiology : JVIR - Category: Radiology Authors: Tags: Laboratory Investigation Source Type: research
The risk of stent thrombosis (ST) or target lesion revascularization (TLR) is increased with smaller stent diameters (SD). Whether SD has a deleterious effect in women treated with early- vs. new-generation drug-eluting stents (DES) is unknown.
Source: International Journal of Cardiology - Category: Cardiology Authors: Tags: Short communication Source Type: research
It is unclear whether universal access to primary percutaneous coronary intervention (pPCI) may reduce sex differences in 1-year rehospitalization for heart failure (HF) and myocardial infarction (MI) after ST-elevation myocardial infarction (STEMI). We studied 7,597 consecutive STEMI patients (13.8% women, N=1,045) who underwent pPCI from January 2007 to December 2013. Cox regression models adjusted for competing risk from death were used to assess sex differences in rehospitalization for HF and MI within 1 year from discharge.
Source: The American Journal of Cardiology - Category: Cardiology Authors: Source Type: research
Limited data on sex differences by ethnicity following percutaneous coronary intervention (PCI) exist. In this prospective cohort study, we examined sex differences in 1-year outcomes among patients from 4 ethnic groups who underwent PCI from 2010-2016 at a tertiary center. The primary outcome was 1-year major adverse cardiovascular events (MACE) defined as composite of all-cause death, non-fatal myocardial infarction (MI), or target lesion revascularization (TLR).Secondary outcomes included composite of death or MI and individual components of MACE.
Source: The American Journal of Cardiology - Category: Cardiology Authors: Source Type: research
There's a new surgical robot on the market in Europe and the Middle East, and this one can assist in stenting procedures such as angioplasty. Rouen, France-based Robocath developed R-One, which is the first European robotic solution to obtain the CE mark in the field of interventional cardiology. R-One is designed to enable precision technologies that complement existing methods, in order to improve procedures and the working environment. The company said the device uses a unique technology that optimizes the safety of robotic-assisted coronary angioplasty. The R-One has an open architecture so it i...
Source: MDDI - Category: Medical Devices Authors: Tags: Cardiovascular Source Type: news
More News: Angioplasty | Beta-Blockers | Cardiology | General Medicine | Heart | Inderal | Study | Toprol